Skip to content Skip to navigation
University of Warwick
  • Study
  • |
  • Research
  • |
  • Business
  • |
  • Alumni
  • |
  • News
  • |
  • About

University of Warwick
Publications service & WRAP

Highlight your research

  • WRAP
    • Home
    • Search WRAP
    • Browse by Warwick Author
    • Browse WRAP by Year
    • Browse WRAP by Subject
    • Browse WRAP by Department
    • Browse WRAP by Funder
    • Browse Theses by Department
  • Publications Service
    • Home
    • Search Publications Service
    • Browse by Warwick Author
    • Browse Publications service by Year
    • Browse Publications service by Subject
    • Browse Publications service by Department
    • Browse Publications service by Funder
  • Statistics
  • Help & Advice
University of Warwick

The Library

  • Login

Modelling the hepatitis B vaccination programme in prisons

Tools
- Tools
+ Tools

Sutton, A. J., Gay, N. J., Edmunds, W. John , Andrews, N. J., Hope, V. D., Gilbert, R. L., Piper, M. and Gill, O. N.. (2006) Modelling the hepatitis B vaccination programme in prisons. Epidemiology and Infection, Vol.13 (No.2). pp. 231-242. ISSN 0950-2688

[img]
Preview
PDF
WRAP_Sutton_Modelling_hepititus_prison.pdf - Requires a PDF viewer such as GSview, Xpdf or Adobe Acrobat Reader

Download (190Kb)
Official URL: http://dx.doi.org/10.1017/S0950268805005182

Abstract

A vaccination programme offering hepatitis B (HBV) vaccine at reception into prison has been introduced into selected prisons in England and Wales. Over the coming years it is anticipated this vaccination programme will be extended. A model has been developed to assess the potential impact of the programme on the vaccination coverage of prisoners, ex-prisoners, and injecting drug users (IDUs). Under a range of coverage scenarios, the model predicts the change over time in the vaccination status of new entrants to prison, current prisoners and IDUs in the community. The model predicts that at baseline in 2012 57% of the IDU population will be vaccinated with up to 72% being vaccinated depending on the vaccination scenario implemented. These results are sensitive to the size of the IDU population in England and Wales and the average time served by an IDU during each prison visit. IDUs that do not receive HBV vaccine in the community are at increased risk from HBV infection. The HBV vaccination programme in prisons is an effective way of vaccinating this hard-to-reach population although vaccination coverage on prison reception must be increased to achieve this.

Item Type: Journal Article
Subjects: R Medicine > RA Public aspects of medicine > RA0421 Public health. Hygiene. Preventive Medicine
H Social Sciences > HV Social pathology. Social and public welfare
Divisions: Faculty of Science > Life Sciences (2010- ) > Biological Sciences ( -2010)
Library of Congress Subject Headings (LCSH): Hepatitis B -- Vaccination -- Great Britain, Prisoners -- Health and hygiene -- Great Britain, Prisoners -- Medical care -- Great Britain, Vaccination -- Great Britain, Communicable diseases -- Prevention
Journal or Publication Title: Epidemiology and Infection
Publisher: Cambridge University Press
ISSN: 0950-2688
Date: April 2006
Volume: Vol.13
Number: No.2
Page Range: pp. 231-242
Identification Number: 10.1017/S0950268805005182
Status: Peer Reviewed
Access rights to Published version: Open Access
Funder: Great Britain. HM Prison Service (HMPS), Great Britain. Dept. of Health (DoH)
References: 1. Laboratory reports of hepatitis B in England and Wales. Commun Dis Rep CDR Rev 2003; 13 (35). 2. Unlinked Anonymous Surveys Steering Group. Prevalence of HIV and Hepatitis Infections in the United Kingdom 2001: Annual Report of the Unlinked Anonymous Prevalence Monitoring Programme. Department of Health. 3. Harm minimisation. Prison Health Newsletter 2001 [4], 5. 4. Sutton AJ, Gay NJ, Edmunds WJ, Andrews NJ, Hope VD, Gill O. Modelling the characteristics of the males injecting drug user population in England and Wales. Inter J Drug Policy (in press). 5. Weild AR, Gill ON, Bennett D, Livingstone SJ, Parry JV, Curran L. Prevalence of HIV, hepatitis B, and hepatitis C antibodies in prisoners in England and Wales: a national survey. Commun Dis Public Health 2000; 3: 121–126. 6. Home Office. Prison Statistics England and Wales 2001. 7. Bennett T. Drugs and crime: the results of the second developmental stage of the NEW-ADAM programme, 2000. London, Home Office. Home Office Research Study; 205. 8. Seaman SR, Gore SM, Brettle RP. Injecting drug users in Edinburgh have a high rate of recidivism. Addiction 2000; 95: 791–792. 9. Francois G, Hallauer J, Van Damme P. Hepatitis B vaccination: how to reach risk groups. Vaccine 2002; 21: 1–4. 10. Boys A, Farrell M, Bebbington P, et al. Drug use and initiation in prison: results from a national prison survey in England and Wales. Addiction 2002; 97: 1551–1560. 11. McCullagh P, Nelder JA. Generalized linear models (Monographs on Statisitics and Applied Probability). New York: Chapman and Hall, 1989. 12. Population Estimates 2000. England and Wales. Office of National Statistics (ONS). 13. Prime J, White S, Liriano S, Patel K. Criminal careers of those born between 1953 and 1978, England and Wales. 2001, Issue 4. Home Office, Statistical Bulletin.
URI: http://wrap.warwick.ac.uk/id/eprint/710

Request changes to a record

Actions (login required)

View Item View Item

Document Downloads

More statistics for this item...
twitter

Email us: publications@warwick.ac.uk
Contact Details
About Us